<PAGE>
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-A
For Registration of Certain Classes of Securities
Pursuant to Section 12(b) or (g) of the
Securities Exchange Act of 1934
Commission file number: 33-43537
FUTURE MEDICAL TECHNOLOGIES INTERNATIONAL, INC.
(Name of small business issuer in its charter)
Nevada 56-1668867
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
One Glenhardie Corporate Center, 1275 Drummers Lane, Suite 201, Wayne,
Pennsylvania 19087
(Address of principal executive offices) (Zip Code)
Issuer's telephone number: 610-975-9533
If this Form relates to the registration of a class of debt securities and is
effective upon filing pursuant to General Instruction A.(c)(1), please check
the following box: ____
If this Form relates to the registration of a class of debt securities and is
to become effective simultaneously with the effectiveness of a concurrent
registration statement under the Securities Act of 1933 pursuant to General
Instruction A.(c)(2), please check the following box: ____
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on which
to be so registered each class is to be registered
None Inapplicable
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, $.001 Par Value
(Title of Class)
<PAGE>
FORM 8-A
ITEM 1. Description of Registrant's Securities to be Registered
The Registrant seeks to register its common stock, $.001 par value (the "Common
Stock"). As of July 16, 1996, there were 25,000,000 shares of Common Stock
authorized, of which 11,542,401 shares were issued and outstanding. The holders
of the Common Stock (i) have equal rateable rights to dividends from funds
legally available therefrom when, as and if declared by the Board of
Directors of the Registrant; (ii) are entitled to share rateably in all of the
assets of the Registrant available for distribution to holders of Common Stock
upon liquidation, dissolution or winding up of the affairs of the Registrant;
(iii) do not have pre-emptive, subscription or conversion rights and there are
no redemption or sinking fund provisions applicable thereto; and (iv) are
entitled to one non-cumulative vote per share on all matters which stockholders
may vote on at all meetings of stockholders, so that the holders of more than
50% of such outstanding shares, voting for the election of directors, can elect
all of the directors to be elected if they so choose and,in such event, the
holders of the remaining shares will not be able to elect any of the
Registrant's directors. All shares of Common Stock are fully paid for and non-
assessable, with no personal liability attaching to the ownership.
For a more comprehensive description of the Common Stock of the Registrant,
reference is made to the Prospectus dated June 26, 1992 of the Registrant
included in the Registration Statement on Form S-1 Registration Number 33-43537
filed with the Securities & Exchange Commission on October 25, 1991, March 24,
1991 and June 22, 1992.
ITEM 2. Exhibits
1.1 Form of Stock Certificate representing shares of the Registrant's Common
Stock, $.001 par value.
1.2 The following documents heretofore filed by the Registrant with the
Securities and Exchange Commission ("SEC") as Exhibits to the Registration
Statement on Form S-1 (Registration No. 33-43537 filed with the SEC on October
25, 1991, March 24, 1991 and June 22, 1992 are incorporated by reference.
3.1 Certificate of Incorporation of Future Medical Technologies
International, Inc. (formerly West End Ventures, Inc.), a Nevada corporation
(the "Registrant").
3.2 Bylaws of Future Medical Technologies International, Inc.
13.1 Form 10-KSB for the year ending December 31, 1995 heretofore filed
by the Registrant with the Securities and Exchange Commission ("SEC").
13.2 Form 10-QSB for the period ending March 31, 1996 heretofore filed
by the Registrant with the Securities and Exchange Commission ("SEC").
13.3 Form 10-QSB for the period ending June 30, 1996 heretofore filed
by the Registrant with the Securities and Exchange Commission ("SEC").
<PAGE>
Pursuant to the requirements of Section 12 of the Exchange Act of 1934, the
Registrant has duly caused this registration statement to be signed on its
behalf by the undersigned, thereto duly authorized.
FUTURE MEDICAL TECHNOLOGIES
INTERNATIONAL, INC.
Dated: July 23, 1996
By: /s/Bruce LaMont
------------------------
Bruce LaMont, President
and Director
FMTI\FORM8-A.95
